Medicine and Dentistry
Acetylsalicylic Acid
18%
Acute Heart Infarction
7%
Ankle Brachial Index
7%
Anticoagulation
8%
Antiphospholipid Antibody
44%
Antiphospholipid Syndrome
100%
Apoplexy
7%
Brain Ischemia
7%
Cardiovascular Risk
8%
Chronic Kidney Disease
10%
Cohort Analysis
7%
Connective Tissue Disease
14%
COVID-19
8%
Direct Oral Anticoagulant
7%
Disease Activity
8%
Disease Course
10%
Diseases
17%
Health Inequality
7%
Heparin
19%
Household
7%
Humoral Immunity
7%
Hydroxychloroquine
14%
Immunogenicity
7%
Infection
9%
Inflammatory Arthritis
9%
Inflammatory Disorder
7%
Livedo
7%
Livedo reticularis
7%
Low Drug Dose
8%
Lupus Erythematosus
8%
Musculoskeletal Disease
15%
Obstetrics
24%
Phlebothrombosis
7%
Placebo
8%
Pre-Eclampsia
13%
Pregnancy Complication
12%
Prevalence
21%
Prospective Cohort Study
7%
Prospective Study
7%
Rheumatic Disease
44%
Rheumatoid Arthritis
8%
Rheumatology
14%
Risk Stratification
7%
Severe Acute Respiratory Syndrome Coronavirus 2
8%
Social Determinants of Health
7%
Spontaneous Abortion
9%
Stillbirth
8%
Systematic Review
9%
Systemic Lupus Erythematosus
37%
Vitamin K Antagonist
12%
Pharmacology, Toxicology and Pharmaceutical Science
Acetylsalicylic Acid
17%
Acute Heart Infarction
7%
Adverse Event
6%
Alemtuzumab
7%
Anticoagulant Agent
7%
Antiphospholipid Antibody
26%
Antiphospholipid Syndrome
38%
Antirheumatic Agent
7%
Antivitamin K
12%
Autoimmune Disease
9%
Brain Ischemia
7%
Cerebrovascular Accident
7%
Chronic Kidney Failure
7%
Clinical Trial
15%
Cohort Study
8%
Connective Tissue Disease
7%
COVID-19 Vaccine
8%
Dexamethasone
7%
Direct Oral Anticoagulant
7%
Diseases
15%
Erythropoietin
7%
Heparin
17%
Hydroxychloroquine
16%
Immunogenicity
7%
Immunosuppressive Agent
6%
Infection
11%
Inflammatory Arthritis
9%
Multiple Sclerosis
14%
Musculoskeletal Disease
7%
Pandemic
6%
Placebo
7%
Prevalence
8%
Prospective Cohort Study
8%
Prospective Study
7%
Rheumatic Disease
42%
Rheumatoid Arthritis
8%
SARS Coronavirus
8%
Thrombosis
5%
Vasculitis
7%
Immunology and Microbiology
Alemtuzumab
7%
Antibody Specificity
7%
Antiphospholipid Antibody
39%
Antiphospholipid Syndrome
66%
Autoimmune Disease
5%
Connective Tissue
11%
Glycoprotein
5%
Humoral Immunity
7%
Hydroxychloroquine
15%
Immunogenicity
7%
Low Drug Dose
7%
Multiple Sclerosis
7%
Offspring
7%
Prevalence
14%
Rheumatic Disease
30%
Severe Acute Respiratory Syndrome Coronavirus 2
7%
Systemic Lupus Erythematosus
22%
Thrombin
8%
Thrombocyte Activation
7%
Undifferentiated Connective Tissue Disease
7%
Vasculitis
7%